HOME >> MEDICINE >> NEWS
Intestine Transplant Results Reported At American Society Of Transplantation Meeting

CHICAGO, May 18 -- With a one-year survival rate of 72 percent, University of Pittsburgh Medical Center (UPMC) surgeons say intestinal transplantation is a viable and a life-saving option for patients with intestinal failure. They reported their results of 127 transplants -- the most performed at any center -- today at the American Society of Transplantation 18th Annual Meeting and Scientific Sessions.

Overall, children between the ages of 2 and 18 had the best success, with a five-year survival rate of 68 percent, reported Kareem Abu-Elmagd, M.D., Ph.D., FACS, associate professor of surgery and director of intestinal transplantation at the University of Pittsburgh's Thomas E. Starzl Transplantation Institute. In addition, 55, or 95 percent, of the 58 patients currently alive are completely off intravenous nutrition, are eating normal diets and have improved quality of life.

Between May 1990 and March 1999, 127 transplants were performed in 121 adults and children who had irreversible intestinal failure.

The small intestine can be transplanted in one of three ways: alone; in combination with the liver; or in combination with the liver, pancreas and stomach. The majority (81 percent) of the patients at the UPMC required intestinal transplants because of short-gut syndrome, the loss of more than 70 percent of the intestine due to trauma, surgery or disease. For adults, short-gut syndrome may be caused by trauma, clotting of the intestine's vessels or Crohn's disease; for children, it may be a volvulus -- a twisting of the intestines, or congenital conditions.

Of the patients reported, 48 received small bowel alone, 58 received liver and small bowel and 15 received multiple organs.

Surgeons reported that a number of factors have contributed to improved one-year survival, including: improved management of rejection with a three-drug cocktail of tacrolimus, steroids and daclizumab; refined donor and recipient selection criteria; and modif
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
18-May-1999


Page: 1 2 3

Related medicine news :

1. Transplanted bone marrow cells reduce liver fibrosis in mice
2. Transplant of pig tissue may reduce stroke size and damage
3. Roche pledges continued support for Organ Transplantation Research Foundation
4. Transplanted kidneys from living donors survive longer with Neoral compared with tacrolimus
5. National Conference on Organ Donation and Transplantation
6. Transplantation Society reiterates position against selling organs
7. Transplants in HIV patients should proceed, but drug interactions a concern
8. International Congress of the Transplantation Society beginning Sunday
9. JDRF launches multimillion-dollar Center for Islet Transplantation at Emory University
10. Transplanted human neural stem cells improve memory in rats
11. Kidney Transplants From Living Donors Reduce Long-Term Costs Of Care

Post Your Comments:
(Date:8/27/2015)... ... 2015 , ... In mid-May, Logistics Trust, Inc. (“Logistics Trust”) ... of its Doobster platform, a HIPAA-compliant mobile application that allows medical marijuana patients ... and tablets. Well, Doobster, “The App That Delivers!” is here! You ...
(Date:8/27/2015)... ... ... The Naderi Center is proud to announce that its own Dr. Jessica ... fat. The first and only Food and Drug Administration (FDA) approved treatment for ... only Board Certified surgeon in the D.C., Maryland, Virginia area to offer this innovative, ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, ... Glushko, professional Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko ... her training and recovery. , With a focus on technology and comfort, Zensah® ...
(Date:8/27/2015)... OKLAHOMA CITY, OK (PRWEB) , ... August 27, ... ... Partners (“GPP”) I, LP portfolio company and leading biopharmaceutical contract development manufacturing company ... acquired by Hepalink USA Inc. (“Hepalink”) for $205.68M in cash. , ...
(Date:8/27/2015)... , ... August 27, 2015 , ... Susan Harris ... procedure to relieve vaginal discomfort due to pre- and post-menopause, chemotherapy, and child birth. ... CO2 laser, which delivers controlled energy to the vaginal tissue, revitalizing cells so they ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 2Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 3Health News:Great Point Partners, LLC Announces that Hepalink USA Inc. Agrees to Acquire Cytovance Biologics, Inc. 4Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 2Health News:LifeStream Health Centre & MedSpa Announces New Treatment for Vaginal Discomfort 3
(Date:8/27/2015)... , Aug. 27, 2015 Major pharmaceutical and ... at a legal conference in Philadelphia ... emerging issues, Tom Hagy of HB Litigation Conferences ... event, visit HB,s website at http://litigationconferences.com/?p=31886 ... Segal McCambridge Singer & Mahoney and Michelle Hart Yeary ...
(Date:8/27/2015)... 27, 2015 Itamar Medical Ltd. ... investment in public equity (PIPE) deal, in which Viola ... Itamar Medical.   Through this deal, Viola ... Medical and will work closely with the company,s management ... to the investment agreement, Itamar Medical will issue shares ...
(Date:8/27/2015)... , August 27, 2015 ... Persistence Market Research titled "Global Market Study on ... Growth by 2021", the urinary catheters market is expected to ... of 2015. It is anticipated to expand at ... reach US$1,755.0 Mn by 2021. View ...
Breaking Medicine Technology:Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 2Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 3Global Urinary Catheters Market Will Reach US$1,755.0 Mn by 2021: Persistence Market Research 4
Cached News: